ACE-2 Expression and Methylation Pattern in Bronchoalveolar LavageFluid and Bloods of Iranian ARDS Covid-19 Patients

Document Type : Original Article

Authors
1 Genetics Research Center, the University of Social Welfare and Rehabilitation Science, Tehran, Iran.
2 Department of Surgery, School of Medicine, Qazvin University of Medical Sciences, Qazvin, Iran.
3 Khatam Pathobiology and Genetic Lab, Qazvin, Iran.
4 Research Institute for Prevention of Non -Communicable Diseases, Cellular and Molecular Research Centre, Qazvin University of Medical Sciences, Qazvin, Iran.
Abstract
The aim of the present study was to investigate the expression and methylation pattern of the
angiotensin I converting enzyme 2 (ACE
-2) in acute respiratory distress syndrome (ARDS)
covid
-9 patients. A total of 25 patients with covid
-19 ARDS and 20 controls were recruited.
Expression of the ACE
-2 gene was evaluated by quantitative real time PCR, and methylation of
CpG dinucleotides, in the ACE
-2 promoter, was quantified using bisulfite pyro
-sequencing. Our
results showed high expression of the ACE
-2 gene in the blood samples of ADRS patients (1.93±
0.67) in comparison to controls (0.62±0.35) (P = 0.03). Correspondingly, in ARDS
bronchoalveolar lavage fluid (BALF) samples, there was a high expression of this gene (1.8±0.78)
in comparison to controls (0.58±0.2) (p <0.05). Moreover, the methylation rate of the ACE
-2 gene
in blood samples of ARDS patients was 64.07 ±6.1 in comparison to controls (80.3 ±7.3)
(p<0.0001). In BALF samples, there was this pattern too (55.07 ±3.1 vs. 72.35±5.1) (p<0.0001).
Finally, a significant correlation was found between expression and methylation in BALF (R=
-
0.54, P= 0.002) and blood (R=
-0.321, P= 0.013) samples. These results indicated that aberrant
methylation of the ACE
-2 promoter might be associated with high expression of this gene and
the occurrence of ARDS in covid
-19 patients.
Keywords